Skip to main content

buprenorphine transdermal system

NDC 58064-408 · LTS Therapy Systems, LLC

Generic namebuprenorphine
Dosage formPATCH, EXTENDED RELEASE
RouteTRANSDERMAL
Active ingredient(s)BUPRENORPHINE
Strength20 ug/h
Pharmacologic classPartial Opioid Agonist [EPC], Partial Opioid Agonists [MoA]
DEA scheduleCIII
Marketing categoryANDA

Packages

58064-408-04 — 4 POUCH in 1 CARTON (58064-408-04) / 1 PATCH in 1 POUCH (58064-408-11) / 168 h in 1 PATCH

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

42858-839 — Buprenorphine, 47781-406 — buprenorphine, 47781-407 — buprenorphine, 47781-408 — buprenorphine, 47781-419 — buprenorphine, 50742-372 — Buprenorphine, 50742-373 — Buprenorphine, 50742-374 — Buprenorphine, 50742-375 — Buprenorphine, 50742-376 — Buprenorphine, 58284-208 — BUPRENORPHINE, 58284-216 — BUPRENORPHINE, 58284-224 — BUPRENORPHINE, 58284-228 — BUPRENORPHINE, 58284-232 — BUPRENORPHINE, 58284-264 — BUPRENORPHINE, 58284-296 — BUPRENORPHINE, 59011-750 — buprenorphine, 59011-751 — buprenorphine, 59011-752 — buprenorphine, +27 more

From the FDA National Drug Code Directory, retrieved 2026-08-24. Product listings are submitted by labelers; FDA does not verify them.